Marianne Sinn

3.9k total citations · 1 hit paper
49 papers, 1.8k citations indexed

About

Marianne Sinn is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marianne Sinn has authored 49 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 18 papers in Surgery and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marianne Sinn's work include Pancreatic and Hepatic Oncology Research (34 papers), Cancer Genomics and Diagnostics (11 papers) and Neuroendocrine Tumor Research Advances (10 papers). Marianne Sinn is often cited by papers focused on Pancreatic and Hepatic Oncology Research (34 papers), Cancer Genomics and Diagnostics (11 papers) and Neuroendocrine Tumor Research Advances (10 papers). Marianne Sinn collaborates with scholars based in Germany, United Kingdom and Austria. Marianne Sinn's co-authors include Hanno Riess, Helmut Oettle, P. Neuhaus, Klaus Gellert, Jörg Fahlke, Marco Niedergethmann, Axel Hinke, Andreas Hochhaus, C. Zülke and Karsten Ridwelski and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Marianne Sinn

48 papers receiving 1.8k citations

Hit Papers

Adjuvant Chemotherapy With Gemcitabine and Long-term Outc... 2013 2026 2017 2021 2013 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marianne Sinn Germany 15 1.6k 673 601 558 435 49 1.8k
Bernd Doerken Germany 10 1.8k 1.1× 729 1.1× 672 1.1× 509 0.9× 661 1.5× 19 2.1k
Ralf Wilkowski Germany 25 1.3k 0.8× 448 0.7× 533 0.9× 524 0.9× 502 1.2× 48 1.8k
Osamu Kainuma Japan 20 1.6k 1.0× 983 1.5× 789 1.3× 310 0.6× 412 0.9× 80 2.1k
Jörg Fahlke Germany 9 1.3k 0.8× 732 1.1× 650 1.1× 421 0.8× 394 0.9× 21 1.6k
Stefano Cereda Italy 21 1.1k 0.7× 564 0.8× 535 0.9× 323 0.6× 311 0.7× 53 1.5k
Francesco Minni Italy 30 1.7k 1.1× 1.4k 2.1× 887 1.5× 272 0.5× 557 1.3× 137 2.6k
L. Roll Germany 4 1.7k 1.1× 736 1.1× 650 1.1× 530 0.9× 665 1.5× 8 1.9k
Hiroshi Imaoka Japan 27 1.4k 0.9× 1.2k 1.7× 852 1.4× 196 0.4× 522 1.2× 107 2.0k
Olivier Dubreuil France 15 932 0.6× 378 0.6× 498 0.8× 382 0.7× 159 0.4× 56 1.6k
Luis Paz‐Ares Spain 13 784 0.5× 525 0.8× 675 1.1× 239 0.4× 153 0.4× 27 1.6k

Countries citing papers authored by Marianne Sinn

Since Specialization
Citations

This map shows the geographic impact of Marianne Sinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marianne Sinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marianne Sinn more than expected).

Fields of papers citing papers by Marianne Sinn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marianne Sinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marianne Sinn. The network helps show where Marianne Sinn may publish in the future.

Co-authorship network of co-authors of Marianne Sinn

This figure shows the co-authorship network connecting the top 25 collaborators of Marianne Sinn. A scholar is included among the top collaborators of Marianne Sinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marianne Sinn. Marianne Sinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Auer, Timo Alexander, et al.. (2024). Peritoneales Mesotheliom und Pseudomyxoma peritonei. 19(1-2). 8–25. 1 indexed citations
2.
Sinn, Marianne, et al.. (2023). Aktuelle Empfehlungen zu körperlicher Aktivität bei Cancer Survivors – ein narratives Review. B&G Bewegungstherapie und Gesundheitssport. 39(2). 49–55.
4.
Sinn, Marianne, et al.. (2023). Effects of Exercise Training on Patient-Specific Outcomes in Pancreatic Cancer Patients: A Scoping Review. Cancers. 15(24). 5899–5899. 7 indexed citations
5.
Seufferlein, Thomas, Julia Mayerle, Stefan Böck, et al.. (2022). S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL. Zeitschrift für Gastroenterologie. 60(11). e812–e909. 7 indexed citations
6.
Seufferlein, Thomas, Julia Mayerle, Stefan Böck, et al.. (2022). S3-Leitlinie zum exokrinen Pankreaskarzinom – Kurzversion 2.0 – Dezember 2021, AWMF-Registernummer: 032/010OL. Zeitschrift für Gastroenterologie. 60(6). 991–1037. 8 indexed citations
7.
Tachezy, Michael, Tarik Ghadban, Jakob R. Izbicki, et al.. (2022). Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma. Cancers. 14(4). 1084–1084. 4 indexed citations
8.
Striefler, Jana K., Jens Stieler, Christopher Neumann, et al.. (2022). Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation. Journal of Clinical Medicine. 11(16). 4905–4905. 1 indexed citations
9.
Schönlein, Martin, Marc Lütgehetmann, Julian Schulze zur Wiesch, et al.. (2021). Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment. Cancers. 13(15). 3800–3800. 24 indexed citations
10.
Schönlein, Martin, Christian Wiessner, Heiko Becher, et al.. (2021). Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple Myeloma. Journal of Clinical Medicine. 10(23). 5499–5499. 5 indexed citations
11.
Striefler, Jana K., Hanno Riess, Philipp Lohneis, et al.. (2021). Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study. Frontiers in Oncology. 11. 670396–670396. 30 indexed citations
12.
Wörmann, Bernhard & Marianne Sinn. (2019). Position of Scientific Oncological Societies Towards Biosimilar Antibodies. Breast Care. 14(1). 5–8. 3 indexed citations
13.
Pape, Ulrich‐Frank, Stefan Kasper, Marianne Sinn, et al.. (2019). Randomized phase II trial of the carboxylesterase (CES)-converted novel drug EDO-S7.1 in patients (pts) with advanced biliary tract cancers (BTC).. Journal of Clinical Oncology. 37(4_suppl). 264–264. 1 indexed citations
14.
Lohneis, Philipp, Marianne Sinn, Fritz Klein, et al.. (2018). Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma. British Journal of Cancer. 118(11). 1485–1491. 33 indexed citations
15.
Sinn, Marianne, Philipp Jurmeister, Matthias Biebl, et al.. (2018). Two patients with rare mixed adenoneuroendocrine carcinomas of the rectum. SAGE Open Medical Case Reports. 6. 2050313X18758816–2050313X18758816. 8 indexed citations
17.
Sinn, Bruno V., Jana K. Striefler, Annika Lehmann, et al.. (2014). KRAS Mutations in Codon 12 or 13 Are Associated With Worse Prognosis in Pancreatic Ductal Adenocarcinoma. Pancreas. 43(4). 578–583. 34 indexed citations
18.
Sinn, Marianne, Bruno V. Sinn, Jens Stieler, et al.. (2013). SPARC in pancreatic cancer: Results from the CONKO-001 study.. Journal of Clinical Oncology. 31(15_suppl). 4016–4016. 3 indexed citations
19.
Sinn, Marianne, Jens Ricke, Daniel Seehofer, et al.. (2013). Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with primary liver cancer: A phase II-study (NCT00356161). BMC Gastroenterology. 13(1). 125–125. 12 indexed citations
20.
Sinn, Marianne, Sven Bischoff, Oliver Nehls, et al.. (2012). Biliary Tract Cancer: A Survey Regarding the Current Oncological Daily Care Practice in Germany. Onkologie. 35(12). 755–760. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026